Market Place
Sourcing Support
Revarazan Hcl For Acute Gastritis, Chronic Gastritis Gastric Mucosal Lesions
28 Mar 2024 //
PRESS RELEASE
GEFAPIXAN CITRATE-Effective Suppression Of Chronic Cough
13 Mar 2024 //
PRESS RELEASE
US FDA declines to approve Merck`s chronic cough drug
21 Dec 2023 //
BUSINESSWIRE
FDA panel flags insufficient data for Merck`s chronic cough drug
18 Nov 2023 //
REUTERS
FDA skeptical of Merck’s gefapixant, even after cough recount
16 Nov 2023 //
FIERCE BIOTECH
US FDA staff flags concerns about Merck`s chronic cough drug
16 Nov 2023 //
REUTERS
Merck`s Lyfnua (gefapixant) Receives Approval in Europe
10 Oct 2023 //
EMA
Merck Receives Positive European Union CHMP Opinion for Gefapixant
21 Jul 2023 //
BUSINESSWIRE
GSK inks $2B Bellus buyout to challenge Merck for cough market
19 Apr 2023 //
FIERCE BIOTECH
Merck responds to FDA letter for chronic cough med gefapixant
06 Aug 2022 //
FIERCEBIOTECH
Merck drug for chronic cough rejected by FDA
24 Jan 2022 //
PRESS RELEASE
U.S. FDA Accepts Merck’s Gefapixant New Drug Application for Review
25 Feb 2021 //
BUSINESSWIRE
Higher dose of gefapixant hits endpoints in chronic cough trial
18 Mar 2020 //
PHARMATIMES
Compugen Announces Closing of $75 Million Public Offering of Ordinary Shares
17 Mar 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.